FTC in­ves­ti­gates J&J con­tracts re­gard­ing the drug­mak­er's block­buster Rem­i­cade

In Sep­tem­ber 2017, Pfiz­er filed a law­suit al­leg­ing that J&J was col­lud­ing with in­sur­ers to en­sure the com­pa­ny’s block­buster au­toim­mune dis­ease drug, Rem­i­cade, was giv­en …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER